Locked Nucleic Acid in Situ Hybridization Analysis of MiR-21 Expression During Colorectal Cancer Development
Overview
Authors
Affiliations
Purpose: To better understand microRNA miR-21 function in carcinogenesis, we analyzed miR-21 expression patterns in different stages of colorectal cancer development using in situ hybridization (ISH).
Experimental Design: Locked nucleic acid (LNA)/DNA probes and a biotin-free tyramide signal amplification system were used in ISH analyses of miRNA expression. Conditions for specific detection of miR-21 were determined using human cell lines and miR-21-expressing lentiviral vectors. Expression was determined in 39 surgically excised colorectal tumors and 34 endoscopically resected colorectal polyps.
Results: In the surgical samples, miR-21 expression was much higher in colorectal cancers than in normal mucosa. Strong miR-21 expression was also observed in cancer-associated stromal fibroblasts, suggesting miR-21 induction by cancer-secreted cytokines. Protein expression of PDCD4, a miR-21 target, was inversely correlated with miR-21 expression, confirming that miR-21 is indeed a negative regulator of PDCD4 in vivo. In the endoscopic samples, miR-21 expression was very high in malignant adenocarcinomas but was not elevated in nontumorigenic polyps. Precancerous adenomas also frequently showed miR-21 up-regulation.
Conclusion: Using the LNA-ISH system for miRNA detection, miR-21 was detectable in precancerous adenomas. The frequency and extent of miR-21 expression increased during the transition from precancerous colorectal adenoma to advanced carcinoma. Expression patterns of miR-21 RNA and its target, tumor suppressor protein PDCD4, were mutually exclusive. This pattern may have clinical application as a biomarker for colorectal cancer development and might be emphasized by self-reinforcing regulatory systems integrated with the miR-21 gene, which has been previously shown in cell culture.
Sadri S, Aghajani A, Soleimani H, Ghorbani Kalkhajeh S, Nazari H, Brouki Milan P Biochem Genet. 2024; .
PMID: 39636332 DOI: 10.1007/s10528-024-10988-y.
Li M, Li Z, Wu X, Yubo Pan , Wang L, Xue J BMC Cancer. 2024; 24(1):1413.
PMID: 39548458 PMC: 11568529. DOI: 10.1186/s12885-024-13154-0.
Mature microRNA-binding protein QKI promotes microRNA-mediated gene silencing.
Min K, Jo M, Song M, Lee J, Shim M, Kim K RNA Biol. 2024; 21(1):1-15.
PMID: 38372062 PMC: 10878027. DOI: 10.1080/15476286.2024.2314846.
Sakurai K, Yamada S, Ito R, Ochiai M, Ando T, Sakai Y Noncoding RNA Res. 2023; 9(1):76-83.
PMID: 38075206 PMC: 10700117. DOI: 10.1016/j.ncrna.2023.11.004.
Skourti E, Volpe A, Lang C, Johnson P, Panagaki F, Fruhwirth G Front Immunol. 2023; 14:1180233.
PMID: 37359535 PMC: 10285160. DOI: 10.3389/fimmu.2023.1180233.